Reports for TEVA-CYCLOBENZAPRINE
Brand name
TEVA-CYCLOBENZAPRINE
Company Name
TEVA CANADA LIMITED
|
Drug Identification Number
02080052 |
Ingredients
CYCLOBENZAPRINE HYDROCHLORIDE |
Ingredient Strength
10 MG |
ATC Code
M03BXM03BX |
ATC Descriptor
MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS |
Status
MARKETED
|
Shortage reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|
TEVA-CYCLOBENZAPRINE | 500 | Resolved | 2021-07-08 | 2021-12-08 | 142195 |
TEVA-CYCLOBENZAPRINE | 500 | Resolved | 2021-07-29 | 2021-08-05 | 143259 |
TEVA-CYCLOBENZAPRINE | 500 | Resolved | 2022-09-30 | 2023-01-19 | 170773 |
TEVA-CYCLOBENZAPRINE | 100 | Resolved | 2024-03-28 | 2024-05-03 | 223838 |
TEVA-CYCLOBENZAPRINE | 100 | Actual shortage | 2024-08-30 | 2024-09-12 | 236365 |
TEVA-CYCLOBENZAPRINE | 500 | Actual shortage | 2024-10-17 | 2024-11-01 | 240513 |
Showing 1 to 6 of 6
Discontinuation reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|
Showing 1 to 0 of 0